ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Improving outcomes for patients with advanced renal cell carcinoma"
Episode Synopsis
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Cristina Suárez, a clinician in Spain with a specialist focus on genitourinary tumors, in conversation with Dr Toni Choueiri, a renal cell carcinoma (RCC) expert. They respond to questions submitted by the HCP audience and provide their expert insights on how emerging combination therapies in the first-line setting can improve outcomes for patients with advanced RCC.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Exelixis, Inc., and Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/in-conversation-improving-outcomes-advanced-rcc-role-of-emerging-combinations-first-line/
Listen to Dr Cristina Suárez, a clinician in Spain with a specialist focus on genitourinary tumors, in conversation with Dr Toni Choueiri, a renal cell carcinoma (RCC) expert. They respond to questions submitted by the HCP audience and provide their expert insights on how emerging combination therapies in the first-line setting can improve outcomes for patients with advanced RCC.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Exelixis, Inc., and Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/in-conversation-improving-outcomes-advanced-rcc-role-of-emerging-combinations-first-line/
In God we trust